XML 73 R56.htm IDEA: XBRL DOCUMENT v3.25.3
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Millions
12 Months Ended
Nov. 01, 2024
Sep. 20, 2024
Oct. 31, 2025
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2022
Gain (Loss) on Disposition of Assets            
Proceeds from Divestiture of Businesses     $ 0 $ 0 $ 50  
Net gain on Divestiture of Business     0 0 43  
Advertising Expense            
Advertising costs expensed as incurred     50 49 54  
Cash and Cash Equivalents            
Short-term Investments     0 0    
Cash and cash equivalents     1,789 1,329 1,590  
Restricted Cash     2 3 3  
Cash, cash equivalents and restricted cash     1,791 1,332 1,593 $ 1,056
Goodwill and Intangible Assets            
Goodwill impairment $ 0   0 0 0  
Impairment of indefinite-lived intangible assets     0 6 0  
In-Process R&D     0 0    
Long -Lived Assets            
Impairment of Long-Lived Assets     15 19 277  
Variable Interest Entity            
Assets     12,727 11,846    
Investments            
Equity Method Investments     0 0    
Employee Compensation and Benefits            
Employee compensation and benefits accrued     129 116    
Share-based Payment Arrangement, Noncash Expense [Abstract]            
Share-based compensation expense     129 130 112  
Foreign Currency Translation            
Foreign currency translation net gain (Ioss)     (3) 4 2  
Senior Notes            
Fair Value Disclosures            
Senior Notes Carrying Value     $ 3,330 $ 3,326    
Accounts Receivable            
Accounts Receivable            
Percent of Accounts receivable from a single customer     No single customer accounted for more than 10 percent of accounts receivable No single customer accounted for more than 10 percent of accounts receivable    
Quoted Prices in Active Markets for Identical Assets (Level 1) | Senior Notes            
Fair Value Disclosures            
Senior Notes Fair Value     $ 3,191 $ 3,083    
Variable Interest Entity, Not Primary Beneficiary            
Variable Interest Entity            
Assets     44 $ 79    
Non-US            
Cash and Cash Equivalents            
Cash and cash equivalents     $ 1,656      
Resolution Bioscience, Inc.            
Gain (Loss) on Disposition of Assets            
Proceeds from Divestiture of Businesses         50  
Net gain on Divestiture of Business         43  
Long -Lived Assets            
Long lived assets held for sale Impairment         270  
BIOVECTRA            
Business Combination [Line Items]            
Purchase price for acquisition   $ 915        
Minimum            
Goodwill and Intangible Assets            
Finite Lived Intangible Assets Useful Life     2 years      
Minimum | Machinery and Equipment            
Property, Plant and Equipment [Abstract]            
Property, Plant and Equipment, Useful Life     3 years      
Minimum | Software Development            
Property, Plant and Equipment [Abstract]            
Property, Plant and Equipment, Useful Life     3 years      
Maximum            
Goodwill and Intangible Assets            
Finite Lived Intangible Assets Useful Life     13 years      
Maximum | Machinery and Equipment            
Property, Plant and Equipment [Abstract]            
Property, Plant and Equipment, Useful Life     10 years      
Maximum | Software Development            
Property, Plant and Equipment [Abstract]            
Property, Plant and Equipment, Useful Life     5 years      
Life Sciences and Diagnostics Markets | Resolution Bioscience, Inc.            
Gain (Loss) on Disposition of Assets            
Goodwill adjustment related to divestiture of business         $ (13)